PURPOSE: To determine if the patterns uncovered with variational Bayesian-independent component analysis-mixture model (VIM) applied to a large set of normal and glaucomatous fields obtained with the Swedish Interactive Thresholding Algorithm (SITA) are distinct, recognizable, and useful for modeling the severity of the field loss. METHODS: SITA fields were obtained with the Humphrey Visual Field Analyzer (Carl Zeiss Meditec, Inc, Dublin, California) on 1,146 normal eyes and 939 glaucoma eyes from subjects followed by the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. VIM modifies independent component analysis (ICA) to develop separate sets of ICA axes in the cluster of normal fields and the 2 clusters of abnormal fields. Of 360 models, the model with the best separation of normal and glaucomatous fields was chosen for creating the maximally independent axes. Grayscale displays of fields generated by VIM on each axis were compared. SITA fields most closely associated with each axis and displayed in grayscale were evaluated for consistency of pattern at all severities. RESULTS: The best VIM model had 3 clusters. Cluster 1 (1,193) was mostly normal (1,089, 95% specificity) and had 2 axes. Cluster 2 (596) contained mildly abnormal fields (513) and 2 axes; cluster 3 (323) held mostly moderately to severely abnormal fields (322) and 5 axes. Sensitivity for clusters 2 and 3 combined was 88.9%. The VIM-generated field patterns differed from each other and resembled glaucomatous defects (eg, nasal step, arcuate, temporal wedge). SITA fields assigned to an axis resembled each other and the VIM-generated patterns for that axis. Pattern severity increased in the positive direction of each axis by expansion or deepening of the axis pattern. CONCLUSIONS: VIM worked well on SITA fields, separating them into distinctly different yet recognizable patterns of glaucomatous field defects. The axis and pattern properties make VIM a good candidate as a preliminary process for detecting progression.
PURPOSE: To determine if the patterns uncovered with variational Bayesian-independent component analysis-mixture model (VIM) applied to a large set of normal and glaucomatous fields obtained with the Swedish Interactive Thresholding Algorithm (SITA) are distinct, recognizable, and useful for modeling the severity of the field loss. METHODS: SITA fields were obtained with the Humphrey Visual Field Analyzer (Carl Zeiss Meditec, Inc, Dublin, California) on 1,146 normal eyes and 939 glaucoma eyes from subjects followed by the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. VIM modifies independent component analysis (ICA) to develop separate sets of ICA axes in the cluster of normal fields and the 2 clusters of abnormal fields. Of 360 models, the model with the best separation of normal and glaucomatous fields was chosen for creating the maximally independent axes. Grayscale displays of fields generated by VIM on each axis were compared. SITA fields most closely associated with each axis and displayed in grayscale were evaluated for consistency of pattern at all severities. RESULTS: The best VIM model had 3 clusters. Cluster 1 (1,193) was mostly normal (1,089, 95% specificity) and had 2 axes. Cluster 2 (596) contained mildly abnormal fields (513) and 2 axes; cluster 3 (323) held mostly moderately to severely abnormal fields (322) and 5 axes. Sensitivity for clusters 2 and 3 combined was 88.9%. The VIM-generated field patterns differed from each other and resembled glaucomatous defects (eg, nasal step, arcuate, temporal wedge). SITA fields assigned to an axis resembled each other and the VIM-generated patterns for that axis. Pattern severity increased in the positive direction of each axis by expansion or deepening of the axis pattern. CONCLUSIONS: VIM worked well on SITA fields, separating them into distinctly different yet recognizable patterns of glaucomatous field defects. The axis and pattern properties make VIM a good candidate as a preliminary process for detecting progression.
Authors: Pamela A Sample; Michael H Goldbaum; Kwokleung Chan; Catherine Boden; Te-Won Lee; Christiana Vasile; Andreas G Boehm; Terrence Sejnowski; Chris A Johnson; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2002-08 Impact factor: 4.799
Authors: Michael H Goldbaum; Pamela A Sample; Zuohua Zhang; Kwokleung Chan; Jiucang Hao; Te-Won Lee; Catherine Boden; Christopher Bowd; Rupert Bourne; Linda Zangwill; Terrence Sejnowski; David Spinak; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2005-10 Impact factor: 4.799
Authors: Michael H Goldbaum; Pamela A Sample; Kwokleung Chan; Julia Williams; Te-Won Lee; Eytan Blumenthal; Christopher A Girkin; Linda M Zangwill; Christopher Bowd; Terrence Sejnowski; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2002-01 Impact factor: 4.799
Authors: M H Goldbaum; P A Sample; H White; B Côlt; P Raphaelian; R D Fechtner; R N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 1994-08 Impact factor: 4.799
Authors: Pamela A Sample; Catherine Boden; Zuohua Zhang; John Pascual; Te-Won Lee; Linda M Zangwill; Robert N Weinreb; Jonathan G Crowston; Esther M Hoffmann; Felipe A Medeiros; Terrence Sejnowski; Michael Goldbaum Journal: Invest Ophthalmol Vis Sci Date: 2005-10 Impact factor: 4.799
Authors: Pamela A Sample; Kwokleung Chan; Catherine Boden; Te-Won Lee; Eytan Z Blumenthal; Robert N Weinreb; Antje Bernd; John Pascual; Jiucang Hao; Terrence Sejnowski; Michael H Goldbaum Journal: Invest Ophthalmol Vis Sci Date: 2004-08 Impact factor: 4.799
Authors: Michael H Goldbaum; Intae Lee; Giljin Jang; Madhusudhanan Balasubramanian; Pamela A Sample; Robert N Weinreb; Jeffrey M Liebmann; Christopher A Girkin; Douglas R Anderson; Linda M Zangwill; Marie-Josee Fredette; Tzyy-Ping Jung; Felipe A Medeiros; Christopher Bowd Journal: Invest Ophthalmol Vis Sci Date: 2012-09-25 Impact factor: 4.799
Authors: Tobias Elze; Louis R Pasquale; Lucy Q Shen; Teresa C Chen; Janey L Wiggs; Peter J Bex Journal: J R Soc Interface Date: 2015-02-06 Impact factor: 4.118
Authors: Michael H Goldbaum; Igor Kozak; Jiucang Hao; Pamela A Sample; TeWon Lee; Igor Grant; William R Freeman Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-09-24 Impact factor: 3.117
Authors: Christopher Bowd; Robert N Weinreb; Madhusudhanan Balasubramanian; Intae Lee; Giljin Jang; Siamak Yousefi; Linda M Zangwill; Felipe A Medeiros; Christopher A Girkin; Jeffrey M Liebmann; Michael H Goldbaum Journal: PLoS One Date: 2014-01-30 Impact factor: 3.240
Authors: Siamak Yousefi; Madhusudhanan Balasubramanian; Michael H Goldbaum; Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb; Jeffrey M Liebmann; Christopher A Girkin; Christopher Bowd Journal: Transl Vis Sci Technol Date: 2016-05-03 Impact factor: 3.283